John Libbey Eurotext

Médecine et Santé Tropicales

The contribution of the French Muskoka Fund to improving access to essential medicines and priority health products for mothers and children Volume 26, issue 4, Octobre-Novembre-Décembre 2016

Figures

  • Figure 1
Authors
J.-B. Nikiema conseillers de l’OMSa 2
1 Département médicaments essentiels et produits de santé, Siège de l’OMS, 20, avenue Appia 1211 Genève 27 Suisse
2 Bureau de l’OMS pour l’Afrique, Cité du Djoué, Brazzaville, République du Congo
* Correspondance
a Conseillers de l’OMS en charge des médicaments et produits de santé au Bénin, au Burkina Faso, en Côte d’Ivoire, en République démocratique du Congo, en Guinée, au Mali, au Niger, au Sénégal et au Togo
  • Key words: essential medicines, health products, regulation, supplies, rational use
  • DOI : 10.1684/mst.2016.0612
  • Page(s) : 367-70
  • Published in: 2016

One objective of the French Muskoka Fund since 2011 has been to improve the availability of quality healthcare services for mothers and children and thus to contribute to the continued presence of essential drugs and affordable quality health products and to their rational use by healthcare personnel. This project thus contributed to reinforcing the work of the national regulatory authorities, guarantor of the quality of the products supplied to the populations, but also to strengthening the coordination of supplies at the country level. It also enabled the provision of support for the implementation of drug price controls and helped to strengthen the ability of healthcare staff to optimize their use of the products available to them. This work should be continued in these countries as they meet the agenda of the Sustainable Development Goals, which require the establishment of universal healthcare coverage.